Pre-diabetes Clinical Trial
Official title:
Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy
The investigators hypothesize that sitagliptin will significantly reduce impairments in insulin secretion and insulin resistance resulting from short-term oral glucocorticoid therapy.
The investigators plan to conduct a prospective, randomized, double-blind, placebo-controlled
parallel arm crossover study comparing insulin secretion and insulin resistance in subjects
with impaired fasting glucose on oral glucocorticoid therapy + placebo versus subjects on
oral glucocorticoid therapy + sitagliptin. For the oral glucocorticoid therapy, we plan to
use dexamethasone (dex) 2.5 mg daily. We chose dex for known glycemic effects, improved
compliance, and once daily dosing.
Previous studies have shown that in humans, glucocorticoid-induced insulin resistance
develops within 4 hours with infused drug at high dose (methylprednisolone 500 mg x single
infusion) and does not change with duration of drug therapy of up to 3 months.10 Furthermore,
more modest doses over a short duration (dex 2.0 mg orally daily x 2 days) have been shown to
decrease insulin-mediated glucose disposal.11 12 Thus, studying acute effects of oral dex at
2.5 mg daily x 7 days should be more than adequate to achieve impaired glucose-mediated
insulin secretion and impaired insulin-mediated glucose disposal.
In order for sitagliptin to have the desired effect, drug should be administered for at least
7 days (5 half-lives plus 40% more for margin of error). We plan to study subjects with
impaired fasting glucose or impaired glucose tolerance as they would likely be candidates for
DPP-IV therapy in the future and would be likely to have impaired insulin secretion and
impaired glucose disposal amenable to DPP-IV therapy.
A total of 10 participants were enrolled in this study. Participants were given 2.5 mg
dexamethasone daily plus either placebo tablet or sitagliptin daily for 8 days with a washout
period prior to crossover. The order of study drug administration was randomized.
Participants underwent blood sampling, mixed meal testing (MMT), and intravenous glucose
tolerance testing (IVGTT) before and after each study period.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Enrolling by invitation |
NCT05367024 -
Broccoli Effect on Glycated Haemoglobin (HbA1c)
|
N/A | |
Completed |
NCT02933424 -
Project Plant Protein: the P3 Study in Humans
|
N/A | |
Withdrawn |
NCT02400450 -
Designer Functional Foods on Parameters of Metabolic and Vascular in Prediabetes
|
N/A | |
Completed |
NCT02656212 -
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)
|
Phase 1 | |
Completed |
NCT02330276 -
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin
|
Phase 1 | |
Completed |
NCT00831129 -
A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs
|
Phase 2/Phase 3 | |
Completed |
NCT00536250 -
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
|
N/A | |
Recruiting |
NCT05563090 -
Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
|
||
Active, not recruiting |
NCT04991142 -
Models of Nutrition From Continuous Glucose Monitors
|
||
Completed |
NCT02759055 -
Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard)
|
N/A | |
Completed |
NCT00775684 -
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
|
N/A | |
Completed |
NCT03695913 -
Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes
|
N/A | |
Completed |
NCT04051008 -
CTSI Pilot: Improving Adherence to Diabetic Diet
|
N/A | |
Recruiting |
NCT04897945 -
A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus
|
N/A | |
Not yet recruiting |
NCT04442451 -
Mechanisms of Fatigability With Diabetes
|
N/A | |
Not yet recruiting |
NCT05925933 -
High Protein Diet on Transcriptomic, Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes
|
N/A | |
Active, not recruiting |
NCT05654051 -
The SLIM LIVER Study
|
Phase 2 | |
Completed |
NCT02919397 -
Motivational Instant Messaging and E-diabetes Prevention Programme for High Risk of Type 2 Diabetes
|
N/A | |
Completed |
NCT00589459 -
Gender Differences in Prevalence of Undiagnosed Diabetes in ACS
|